702.685.3230
A personalized approach to appetite control, metabolic balance, and long-term results, tailored to your body and goals.
We use today’s most effective medical tools—injectables and oral medications to support appetite control, metabolic balance, and sustainable weight loss, personalized to your goals.
Once-weekly treatments gently guide appetite and metabolic rhythm, supported by medications such as tirzepatide and semaglutide.
For non-injectable options, daily oral support helps manage cravings and appetite, with options like phentermine or naltrexone/bupropion.
From beauty to recovery to immune support—find the formula that fits your life.
Injectable Weight-Loss Support
We offer two of the most advanced, clinically proven medications for weight loss and metabolic wellness: tirzepatide (Mounjaro®/Zepbound®) and semaglutide (Ozempic®/Wegovy®) These treatments are FDA-approved and backed by extensive research for reducing weight, supporting insulin function, and lowering long-term health risks.
Typical results include
15% average body-weight loss with GLP-1 options
Up to 21% average loss with combination-pathway medications
B‑12 (5000 mg)
Boosts brain function, clarity, and restful sleep
How they work
Both medications belong to a class called GLP-1 receptor agonists, which mimic natural hormones that regulate appetite and insulin. Tirzepatide also activates GIP receptors, offering enhanced metabolic effects.
Semaglutide
Targets GLP-1 to reduce hunger and improve insulin responses
Tirzepatide
Dual action on GLP-1 and GIP for greater weight loss and blood sugar control.
How injectibles help
Oral Medication Options
For patients who prefer a non-injectable route, NuMe also offers oral medication options that can help suppress appetite, regulate cravings, increase metabolism, or reduce fat absorption.
Common choices include
Phentermine: that help regulate cravings, mood, and hunger cues
Naltrexone/Bupropion (Contrave) Combines appetite suppression with mood regulation.
Results You Can Expect
Both medications belong to a class called GLP-1 receptor agonists, which mimic natural hormones that regulate appetite and insulin. Tirzepatide also activates GIP receptors, offering enhanced metabolic effects.
Semaglutide
Average weight loss of ~15% of body weight
Tirzepatide
Average weight loss of ~21%, with faster onset
Both reduce risk of heart attack, stroke, and death in patients with obesity or type 2 diabetes
Many patients can experience:
We monitor your progress closely and adjust your plan as needed to keep you feeling your best. Most patients tolerate treatment well, some may experience side effects.
Side effects may include:
Your provider will help determine the right approach based on your goals, labs, and medical history.
You may be a great candidate if you
We’ll personalize your care based on your goals, labs, and medical history.
Full consultation + lab review
Personalized treatment plan
Weekly or monthly medication support
Optional B12 supplementation
Ongoing coaching and lifestyle guidance
Transparent pricing with no surprises
